Breast and Cervical Cancer
ACS Effectively Messaging Cancer Screening During the COVID-19 Pandemic
These American Cancer Society resources address cancer screening guidance, effective messaging and the need for action. Please consider using these resources as you engage your communities in resuming preventative cancer screenings.
Effectively Messaging Cancer Screening Issue Brief.
2021 Messaing Guidebook.
Cancer Won't Wait and Neither Should You- Resume Cancer Screening and Treatment Fact Sheet.
Major U.S. Cancer Centers and Organizations Endorse Goal of Resuming Cancer Screening and Treatment during the COVID-19 Pandemic.
Society for Breast Imaging Recommendations
Recently, the Society for Breast Imaging released a recommendation that people undergo mammography screening either before receiving the COVID-19 vaccine or wait to have a mammogram four to six weeks following their second dose of the COVID-19 vaccine. One side effect of the vaccine is enlarged lymph nodes that could raise alarm during a routine mammogram, causing additional unnecessary imaging.
You might consider asking your participants about their COVID-19 vaccination status, including when they received the vaccine. To minimize anxiety, consider telling participants that vaccines of all types can result in temporary swelling of the lymph nodes, which may be a sign that the body is making antibodies as intended. If a person comes to you with signs or symptoms of breast cancer, they should not delay imaging due to vaccination status. Diagnostic mammogram screening should proceed without delay.
Please talk to your program consultant about any impacts you are experiencing in your service area. Reach out to us with any questions as well.
New Program Tools
CFY fillable enrollment form. We hope this paperless option allows you to communicate in more efficient ways. Paperless fillable program enrollment form. We hope this
FY21 updated CFY approved CPT code listing. Please share this with your health care providers or direct them to the website at: https://idph.iowa.gov/cfy/information-for-healthcare-providers
2021 Income Guidelines are now available. Please use these guidelines to determine participant eligibility.
Updated Facility/Provider Listing, Radiology Provider Listing, and Laboratory Provider Listing.
Timely Data Entry Reminder
This is a friendly reminder and request that you enter all BCC consents into the University of Iowa Database within one week of program enrollment. We understand many of you are already doing this as soon as possible. Claims continue to be received faster than ever - in some cases two days after a person receives services. If MBS does have the consent information from the University of Iowa database, the person's claim could be denied because they won't show as being a program member.
We know you are all busy, and we also know that your program participants are your first priority. No one wants them to receive a bill. By working together, hopefully we can prevent that from happening. If you have specific questions or concerns about entering consent information, please let us know.
To help navigate the new COVID-19 medical landscape, the Iowa Breast and Cervical Cancer Program has implemented the following program updates. Please reach out to your Program Consultant with any questions or concerns.
Verbal Consent for Enrollment
Verbal consent for enrollment into the program is now available.
Standard written consent is still the preferred method of enrollment into the Care for Yourself Program. This completed form must be securely kept with the rest of the participant's file.
Virtual Healthcare Visits
The CDC has given the approval to pay for telehealth visits during this public health emergency. The same approved routine office visit codes and reimbursement fees should be used to avoid billing issues.
Clinical Breast Exam Guidance
It is not a requirement for every woman to have a CBE. There are no clinical guidelines stating that a CBE needs to be done before a mammogram. The CBE received an ‘I recommendation’ (inconclusive) by USPSTF because there was not enough scientific evidence to determine if it does or does not reduce breast cancer mortality. Therefore, CDC allows reimbursement for an office visit to perform a CBE, but we do not require a CBE be performed. The decision to have a CBE should be between the woman and her provider. That is one reason why providers should do risk assessments to help determine what examinations a woman should undergo.